Blog

PARTICULARS	31 March 2023	31 March 2022
ASSETS
Non-current assets
Property, Plant and Equipment	32,764.38	34,051.02
Capital work-in-progress	567.26	15.29
Other Intangible assets	44.09	52.97
Right-of-use assets	423.4	479.82
Financial Assets
Other financial assets	1,321.66	1,938.63
Non-current tax assets (net)	458.65	592.53
Other non-current assets	155.15	216.47
	35,734.59	37,346.73
Current assets
Inventories	1,271.85	1,106.15
Financial Assets
Trade receivables	1,998.89	2,013.45
Cash and cash equivalents	3,663.15	1,162.36
Bank balances other than (ii) above	6,178.19	3,898.73
Loans	5.58	6.64
Other financial assets	986.13	669.99
Other current assets	187.33	190.26
	14,291.12	9,047.58
Total Assets	50,025.71	46,394.31
EQUITY AND LIABILITIES
Equity :
Equity Share capital	10,000.00	10,000.00
Other Equity	27,344.92	23,121.22
	37,344.92	33,121.22
Liabilities :
Non-current liabilities
Financial Liabilities
Borrowings	723.56	1,300.95
Lease liabilities	427.46	472.04
Other financial liabilities	–	841.83
Provisions	1,102.09	1,070.88
Deferred tax liabilities (Net)	1,980.75	1,619.83
Other non-current liabilities	327.02	333.26
	4,560.88	5,638.79
Current liabilities
Financial Liabilities
Borrowings	578.85	578.85
Lease liabilities	54.47	51.5
Trade payables
Total outstanding dues of micro enterprises and small enterprises	106.11	138.52
Total outstanding dues of creditors other than micro enterprises and small enterprises	3,433.27	3,181.46
Other financial liabilities	3,521.04	3,295.28
Other current liabilities	318.21	295.52
Provisions	107.96	93.17
	8,119.91	7,634.30
Total Equity and Liabilities	50,025.71	46,394.31

 

Lakeshore Hospital And Research Centre Limited Profit & Loss Statement (Rs. In Lakhs)

PARTICULARS	31 March 2023	31 March 2022
Income:
Revenue from operations	41,918.42	35,858.70
Other income	535.62	307.11
Total Income	42,454.04	36,165.81
Expenses:
Purchase of Medicines & Consumables	11,170.49	10,251.14
Changes in inventories of Medicines & Consumables	-165.7	-186.46
Employee benefits expense	6,383.50	6,282.48
Finance costs	211.01	257.3
Depreciation and amortisation expense	2,269.19	2,146.15
Other expenses	14,344.09	11,337.27
Total expenses	34,212.58	30,087.88
Profit before tax	8,241.46	6,077.93
Tax expense:
Current tax	2,660.93	1,520.99
Tax for earlier years	17.09	7.93
Deferred tax	-188.44	260.94
	2,489.58	1,789.86
Profit for the year	5751.88	4288.07
Other comprehensive income
Items that will not be reclassified to profit or loss
Remeasurements of post employment benefit obligations	-39.76	-187.59
Income tax relating to items that will not be reclassified to profit or loss	11.58	54.63
Total other comprehensive income for the year	-28.18	-132.96
Total Comprehensive Income for the year	5,723.70	4,155.11
Earnings per equity share of Rs 10 each:
Basic (`)	5.75	4.29
Diluted (`)	5.75	4.29

 

Lakeshore Hospital And Research Centre Limited Consolidated Cash Flow Statement (Rs. In Lakhs)

Particulars	31 March 2023	31 March 2022
Cash flow from operating activites
Profit before tax	8,201.70	5,890.34
Adjustments for :
Depreciation and amortisation	2,269.19	2,146.15
Interest expense	211.01	257.3
Interest income	-416.18	-168.7
Net (Profit)/ Loss on sale/write off of Property Plant and Equipment	67.08	237.38
Government grant income	-37.44	-23.34
Bad debts and advances written off	–	–
Provision for doubtful debts	1,098.86	400
Operating cash flow before working capital changes	11,394.22	8,739.13
Movements in working capital :
(Increase) / decrease in inventories	-165.7	-186.46
(Increase) / decrease in trade and other receivables	-2,872.51	-5,629.77
Increase / (decrease) in trade and other payables	-876.04	1,211.64
	7,479.97	4,134.54
Direct taxes paid net of refunds	-1,983.24	-1,015.20
Net cash flows from operating activities (A)	5,496.73	3,119.34
Cashflow from investing activities
Additions to Property, Plant & Equipment (including capital work in progress)	-903.62	-2,645.57
Investment in subsidiaries	–	–
Sale or withdrawal of property, plant and equipment	9.19	124.33
Interest received	229.75	117.51
Net cash flows from investing activites (B)	-664.68	-2,403.73
Cashflow from financing activities
Proceeds/(Repayment) of Buyers credit/ Term Loan	-577.39	-1,841.69
Movement in Short term borrowings (Net)	–	–
Dividend paid	-1,500.67	-497.72
Dividend distribution tax paid	–	–
Payment of lease liabilities	-83.86	-73.81
Interest paid	-169.34	-225.84
Net cash flows from financing activities (C)	-2,331.26	-2,639.06
Net Increase in Cash & Cash Equivalents (A)+(B)+(C)	2,500.79	-1,923.45
Cash and cash equivalent at the beginning of the Year	1,162.36	3,085.81
Cash and cash equivalent at the end of the Year
Cash on hand	23.22	30.79
Balance with Banks in current account and deposit account	3,639.93	1,131.57
Cash and cash equivalents	3,663.15	1,162.36
Net increase/(decrease) in Cash and Cash equivalents	2,500.79	-1,923.45

Let ‘s break down the Cash Flow Statement for the years 2023 and 2022, activity-wise:

1. Cash Flow from Operating Activities:

   – This section begins with the profit before tax, which indicates the company ‘s earnings before tax deductions.

   – Adjustments are made for non-cash expenses like depreciation and amortization, as well as for interest expenses and income.

   – The net profit or loss from the sale or write-off of Property, Plant, and Equipment is accounted for here, along with any government grant income.

   – After these adjustments, the operating cash flow before working capital changes is calculated.

   – Movements in working capital, such as changes in inventories, receivables, and payables, are then factored in.

   – Direct taxes paid, net of refunds, are deducted to arrive at the net cash flows from operating activities.

2. Cash Flow from Investing Activities:

   – This section covers cash flows related to investments in assets and securities.

   – Additions to Property, Plant & Equipment (PPE) are recorded as cash outflows.

   – Any investments made in subsidiaries are also noted.

   – Cash received from the sale or withdrawal of PPE and interest income earned are included.

   – The net cash flows from investing activities are calculated by subtracting cash outflows from cash inflows.

3. Cash Flow from Financing Activities:

   – Financing activities involve cash flows related to raising and repaying capital.

   – Proceeds from or repayments of buyers ‘ credit or term loans are recorded, along with any changes in short-term borrowings.

   – Dividends paid to shareholders and any dividend distribution tax are accounted for as cash outflows.

   – Payments of lease liabilities and interest paid are also included.

   – The net cash flows from financing activities are calculated by summing up cash inflows and outflows.

4. Net Increase in Cash & Cash Equivalents:

   – This section calculates the overall change in cash and cash equivalents during the period.

   – It adds the net cash flows from operating, investing, and financing activities to determine the total increase or decrease in cash.

   – The cash and cash equivalents at the beginning of the year are added to this total to find the ending balance of cash and cash equivalents.

5. Cash and Cash Equivalents at the Beginning and End of the Year:

   – The cash and cash equivalents at the beginning of the year provide the starting point for the analysis.

   – The ending balance of cash and cash equivalents is calculated by adding the net increase or decrease in cash to the beginning balance.

Financial Ratios of Lakeshore Hospital And Research Centre Limited:

Particulars	2023	2022
(a) Current Ratio	1.76	1.19
(b) Debt-Equity Ratio	0.03	0.06
(c) Debt Service Coverage Ratio	9.83	7.81
(d) Return on Equity Ratio	0.16	0.14
(e) Inventory Turnover Ratio	9.26	9.94
(f) Trade Receivables Turnover Ratio	20.89	18.74
(g) Trade Payables Turnover Ratio	3.26	3.10
(h) Net Capital Turnover Ratio	6.79	25.37
(i) Net Profit Ratio	0.14	0.12

Insights into the financial health and performance of the company in 2023 and 2022:

(a) Current Ratio:

   – The current ratio measures a company ‘s ability to pay its short-term obligations with its short-term assets.

   – In 2023, the current ratio is 1.76, indicating that the company has 1.76 times more current assets than current liabilities.

   – In 2022, the current ratio was lower at 1.19, suggesting a potential improvement in the company ‘s liquidity position over the year.

(b) Debt-Equity Ratio:

   – The debt-equity ratio compares a company ‘s total debt to its shareholders ‘ equity.

   – In 2023, the ratio is 0.03, indicating that the company ‘s debt is very low compared to its equity.

   – Similarly, in 2022, the ratio was slightly higher at 0.06, suggesting a slight increase in debt relative to equity compared to 2023.

(c) Debt Service Coverage Ratio:

   – The debt service coverage ratio measures a company ‘s ability to cover its debt obligations with its operating income.

   – In 2023, the ratio is 9.83, indicating a strong ability to cover debt payments with operating income.

   – In 2022, the ratio was slightly lower at 7.81, suggesting a relatively weaker coverage of debt payments compared to 2023.

(d) Return on Equity Ratio:

   – The return on equity (ROE) ratio measures the profitability of a company in relation to its shareholders ‘ equity.

   – In 2023, the ROE ratio is 0.16, indicating that the company generated a return of 16% on its shareholders ‘ equity.

   – In 2022, the ratio was slightly lower at 0.14, suggesting a slight decrease in profitability compared to 2023.

(e) Inventory Turnover Ratio:

   – The inventory turnover ratio measures how efficiently a company manages its inventory.

   – In 2023, the ratio is 9.26, indicating that the company turns over its inventory approximately 9.26 times during the year.

   – In 2022, the ratio was slightly higher at 9.94, suggesting a slight decrease in inventory turnover efficiency compared to 2023.

(f) Trade Receivables Turnover Ratio:

   – The trade receivables turnover ratio measures how efficiently a company collects its accounts receivable.

   – In 2023, the ratio is 20.89, indicating that the company collects its receivables approximately 20.89 times during the year.

   – In 2022, the ratio was slightly lower at 18.74, suggesting a slight improvement in receivables turnover efficiency compared to 2023.

(g) Trade Payables Turnover Ratio:

   – The trade payables turnover ratio measures how efficiently a company manages its accounts payable.

   – In 2023, the ratio is 3.26, indicating that the company pays its suppliers approximately 3.26 times during the year.

   – In 2022, the ratio was slightly lower at 3.10, suggesting a slight decrease in payables turnover efficiency compared to 2023.

(h) Net Capital Turnover Ratio:

   – The net capital turnover ratio measures how efficiently a company utilizes its capital to generate revenue.

   – In 2023, the ratio is 6.79, indicating that the company generates revenue of 6.79 times its net capital.

   – In 2022, the ratio was significantly higher at 25.37, suggesting a notable decrease in capital turnover efficiency compared to 2023.

(i) Net Profit Ratio:

   – The net profit ratio measures the profitability of a company in relation to its revenue.

   – In 2023, the net profit ratio is 0.14, indicating that the company generates a net profit of 14% of its revenue.

   – In 2022, the ratio was slightly lower at 0.12, suggesting a slight decrease in profitability compared to 2023.

Dividend History of Lakeshore Hospital And Research Centre Limited:

Particulars	2023
Dividend (final + interim) (In Rs.)	1.70

 

Annual Reports